News

Read the latest news and updates.

PRiME Connaught Global Challenge Series: Symposium with ETH Zurich

PRiME is hosting the third installment of the Connaught Global Challenge Series introducing our partnership with ETH Zurich. This event will feature investigators from both PRiME and ETH Zurich who are working at the forefront of disease-in-a-dish/on-a-chip models and engineering molecular structure for imaging. Registration for this event is required and additional information along with […]

PRiME and Medicine By Design Co-Host the Cell and Gene Therapies Innovations Showcase

Cell and gene therapies have significant potential to treat the most debilitating of chronic diseases, and will be hugely transformative for the pharmaceutical and biotech industry. In July, PRiME partnered with Medicine by Design to host a virtual Cell and Gene Therapies Innovation Showcase, highlighting novel strategies and enabling technologies poised to advance the field. […]

2019 PRiME Fellows honoured with external funding awards

The PRiME Fellowships have consistently been awarded to an exceptional group of talented, young scientists working on bold interdisciplinary ideas since 2019. It is no surprise that two of these researchers, Anastasia Korolj and Rony Chidiac, have recently been honoured with additional accolades, recognizing their hard work and significant contribution to their respective fields of […]

The PRiME TCAI Team Makes Significant Progress on COVID-19 Research

In April 2020, the University of Toronto was able to quickly mobilize almost $9M through the Toronto COVID-19 Action Fund (TCAI) to support over 30 high impact research projects in the fight against the global COVID-19 pandemic. Many of the members of PRiME’s Task Force on Advanced Diagnostics and Therapeutics for COVID-19 were among the […]

PRiME announces a Pan-Canadian Biomedical Innovation Showcase featuring research and industry leaders

25 January 2021

2020 was an unprecedented year – a global pandemic stopped the world in its tracks. In 2021, we begin our recovery as an economy and a society as a worldwide vaccination effort is rolled out. The importance of biomedical innovation and the biotech sector has never been more evident: the vaccine needed to reopen our […]

PRiME Connaught Global Challenge Series: Symposium with The Hebrew University of Jerusalem

20 January 2021

Following the success of last December’s PRiME-UCSF joint symposium, PRiME is hosting the second instalment of the Connaught Global Challenge Series introducing our partnership with the Hebrew University of Jerusalem (HUJI). This will be a three-part event, featuring investigators from both UofT and HUJI who are working at the forefront of protein engineering, molecular diagnostics, […]

PRiME researchers partner with TIAP and Amgen Inc. for biomanufacturing-focused project

8 December 2020

PRiME Director, Dr. Shana Kelley, together with Drs. Jason Moffat and Stephane Angers, has secured investment from the TIAP-Amgen partnership program to test a high-throughput cell-screening device that can enable the engineering of cells with superior antibody bioproduction capabilities. This collaboration is one of 3 projects recently announced under a strategic partnership between Amgen Inc. […]

PRiME Connaught Global Challenge Series: Global Perspectives to Advance Precision Medicine

12 November 2020

To kick-off PRiME’s new global partnerships program funded by the Connaught Global Challenge Fund, we are launching the Connaught Global Challenge Series which will feature a virtual mini-symposium with each of our four partner institutions. Opening the series next month is a two-day session with the University of California, San Francisco (UCSF), featuring investigators from […]

PRiME awarded Connaught Global Challenge funding to expand global partnerships focused on next-generation precision medicine

The development of new precision medicine-focused approaches requires extensive collaboration and the integration of new technologies. The integration of expertise from across disciplines is essential to create new approaches for diagnosis and the identification of novel treatments from a more complete understanding of disease biology. As PRiME enters its second year as an Institutional Strategic […]

PRiME establishes a Trainee Advisory Committee

28 September 2020

With the 2020-2021 academic year underway, PRiME has convened an inaugural Trainee Advisory Committee with the goal of better integrating trainee perspectives into the development of new initiatives and programming to support our trainee community. Similar to PRiME’s Steering Committee, the Trainee Advisory Committee will have two representatives from each of the Faculties of Arts […]

Team PRiME at the 2020 Terry Fox Run: One Day, Your Way

25 September 2020

The 40th annual Marathon of Hope took place virtually on Sunday, September 20th to celebrate the remarkable Terry Fox and raise money to support cancer research. While we were not able to run together due to this year’s challenges related to COVID-19, members of the PRiME team laced up their running shoes to ensure that […]

PRiME's 2nd Annual Symposium to be held online on October 13th, 2020

15 September 2020

This year PRiME will be holding its symposium virtually on October 13th, 2020. The online event will allow international researchers to join our local community and invited speakers for an afternoon of insightful presentations and discussions. Registration deadline is Friday, October 9th, 2020. Program details are below. NOTE: Advanced registration is required to attend. 1:00 […]

← View newer posts 1 2 3 4 5 View older posts →